المؤلفون: Nguyen HDT; Department of Biomedical Science, Graduate School, Kyungpook National University, Daegu, Republic of Korea.; BK21 Four Program, School of Medicine, Kyungpook National University, Daegu, Republic of Korea., LE TM; Department of Biomedical Science, Graduate School, Kyungpook National University, Daegu, Republic of Korea.; BK21 Four Program, School of Medicine, Kyungpook National University, Daegu, Republic of Korea., Lee D; Department of Biomedical Science, Graduate School, Kyungpook National University, Daegu, Republic of Korea.; BK21 Four Program, School of Medicine, Kyungpook National University, Daegu, Republic of Korea., Cho HJ; Department of Hematology/Oncology, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Republic of Korea., Lee J; Department of Hematology/Oncology, Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University, Daegu, Republic of Korea., Sohn SK; Department of Hematology/Oncology, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Republic of Korea., Kim JG; Department of Hematology/Oncology, Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University, Daegu, Republic of Korea., Ham JY; Department of Laboratory Medicine, Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University, Daegu, Republic of Korea., Moon JH; Department of Hematology/Oncology, Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University, Daegu, Republic of Korea., Han HS; Department of Biomedical Science, Graduate School, Kyungpook National University, Daegu, Republic of Korea.; BK21 Four Program, School of Medicine, Kyungpook National University, Daegu, Republic of Korea., Kim J; Department of Hematology/Oncology, Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University, Daegu, Republic of Korea; dnakim1@gmail.com., Baek DW; Department of Hematology/Oncology, Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University, Daegu, Republic of Korea; baekdw83@gmail.com.

المصدر: In vivo (Athens, Greece) [In Vivo] 2024 Jul-Aug; Vol. 38 (4), pp. 1740-1749.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8806809 Publication Model: Print Cited Medium: Internet ISSN: 1791-7549 (Electronic) Linking ISSN: 0258851X NLM ISO Abbreviation: In Vivo Subsets: MEDLINE

مواضيع طبية MeSH: Bendamustine Hydrochloride*/administration & dosage , Bendamustine Hydrochloride*/pharmacology , Bridged Bicyclo Compounds, Heterocyclic*/pharmacology , Bridged Bicyclo Compounds, Heterocyclic*/administration & dosage , Sulfonamides*/administration & dosage , Sulfonamides*/pharmacology , Drug Synergism* , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/pathology , Antineoplastic Combined Chemotherapy Protocols*/pharmacology , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use, Humans ; Cell Line, Tumor ; Cell Survival/drug effects ; Jurkat Cells ; Apoptosis/drug effects ; Cell Proliferation/drug effects

المؤلفون: Espinoza-Candelaria GJ; Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Mamauag E; Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Bukowinski A; Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Aldewereld Z; Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.

المصدر: The Pediatric infectious disease journal [Pediatr Infect Dis J] 2024 Jul 01; Vol. 43 (7), pp. e255-e256. Date of Electronic Publication: 2024 Mar 13.

نوع المنشور: Case Reports; Letter; Journal Article

بيانات الدورية: Publisher: Williams & Wilkins Country of Publication: United States NLM ID: 8701858 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-0987 (Electronic) Linking ISSN: 08913668 NLM ISO Abbreviation: Pediatr Infect Dis J Subsets: MEDLINE

مواضيع طبية MeSH: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/complications , Anti-Bacterial Agents*/therapeutic use , Micrococcaceae*/isolation & purification, Humans ; Adolescent ; Male ; Treatment Outcome ; Central Nervous System Bacterial Infections/drug therapy ; Central Nervous System Bacterial Infections/microbiology ; Central Nervous System Bacterial Infections/diagnosis ; Actinomycetales Infections/drug therapy ; Actinomycetales Infections/microbiology ; Female

المؤلفون: Rivera M; Division of Regenerative Medicine, Department of Medicine, University of California, San Diego, La Jolla, CA, USA; Moores Cancer Center, La Jolla, CA 92037, USA. Electronic address: mdrivera@health.ucsd.edu., Lim CE; Division of Regenerative Medicine, Department of Medicine, University of California, San Diego, La Jolla, CA, USA; Moores Cancer Center, La Jolla, CA 92037, USA., Jiang Q; Division of Regenerative Medicine, Department of Medicine, University of California, San Diego, La Jolla, CA, USA; Moores Cancer Center, La Jolla, CA 92037, USA. Electronic address: q1jiang@health.ucsd.edu.

المصدر: STAR protocols [STAR Protoc] 2024 Jun 21; Vol. 5 (2), pp. 103103. Date of Electronic Publication: 2024 Jun 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101769501 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-1667 (Electronic) Linking ISSN: 26661667 NLM ISO Abbreviation: STAR Protoc Subsets: MEDLINE

مواضيع طبية MeSH: Coculture Techniques*/methods , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/pathology , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/metabolism, Humans ; Organoids/pathology ; Organoids/cytology ; Cell Proliferation ; Cell Culture Techniques/methods ; Tumor Cells, Cultured

المؤلفون: Tosello V; Basic and Translational Oncology Unit, Istituto Oncologico Veneto IOV-IRCCS, 35128 Padova, Italy., Di Martino L; Dipartimento di Scienze Chirurgiche, Oncologiche e Gastroenterologiche, Università di Padova, 35128 Padova, Italy., Piovan E; Dipartimento di Scienze Chirurgiche, Oncologiche e Gastroenterologiche, Università di Padova, 35128 Padova, Italy.; UOC Immunologia e Diagnostica Molecolare Oncologica, Istituto Oncologico Veneto IOV-IRCCS, 35128 Padova, Italy.

المصدر: International journal of molecular sciences [Int J Mol Sci] 2024 Jun 13; Vol. 25 (12). Date of Electronic Publication: 2024 Jun 13.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/metabolism , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/blood , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/pathology , Receptor, Notch1*/metabolism , Metabolomics*/methods , Biomarkers, Tumor*/blood , Biomarkers, Tumor*/metabolism, Animals ; Mice ; Metabolome ; Disease Models, Animal

المؤلفون: De Coninck S; Department of Biomolecular Medicine, Laboratory of Normal and Malignant Hematopoiesis, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent, Ghent, Belgium.; Department of Diagnostic Sciences, Unit for Translational Research in Oncology, Ghent University, Ghent, Belgium., Roels J; Department of Biomolecular Medicine, Laboratory of Normal and Malignant Hematopoiesis, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent, Ghent, Belgium.; Department of Diagnostic Sciences, Taghon Laboratory, Ghent University, Ghent, Belgium., Lintermans B; Department of Biomolecular Medicine, Laboratory of Normal and Malignant Hematopoiesis, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent, Ghent, Belgium., T'Sas S; Department of Biomolecular Medicine, Laboratory of Normal and Malignant Hematopoiesis, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent, Ghent, Belgium.; Department of Diagnostic Sciences, Unit for Translational Research in Oncology, Ghent University, Ghent, Belgium., Taghon T; Department of Diagnostic Sciences, Taghon Laboratory, Ghent University, Ghent, Belgium., Curtis DJ; Australian Centre for Blood Diseases, Central Clinical School, Monash University, Melbourne, VIC, Australia.; Department of Clinical Haematology, Alfred Hospital, Prahran, VIC, Australia., Pieters T; Department of Biomolecular Medicine, Laboratory of Normal and Malignant Hematopoiesis, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent, Ghent, Belgium.; Department of Diagnostic Sciences, Unit for Translational Research in Oncology, Ghent University, Ghent, Belgium.; Department of Biomolecular Medicine, Laboratory for research in oncogenesis and resistance to therapy, Ghent University, Ghent, Belgium., Goossens S; Cancer Research Institute Ghent, Ghent, Belgium.; Department of Diagnostic Sciences, Unit for Translational Research in Oncology, Ghent University, Ghent, Belgium., Van Vlierberghe P; Department of Biomolecular Medicine, Laboratory of Normal and Malignant Hematopoiesis, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent, Ghent, Belgium.

المصدر: Blood advances [Blood Adv] 2024 Jun 11; Vol. 8 (11), pp. 2646-2649.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/metabolism , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/genetics , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/pathology , Dioxygenases* , Proto-Oncogene Proteins*/metabolism , Proto-Oncogene Proteins*/genetics , DNA-Binding Proteins*/metabolism , DNA-Binding Proteins*/genetics, Humans ; Genes, Tumor Suppressor

المؤلفون: Yu J; Institute of Pediatric Research, Children's Hospital of Soochow University, Suzhou 215003, China., Yang Y; Institute of Pediatric Research, Children's Hospital of Soochow University, Suzhou 215003, China., Zhou R; Department of Pediatrics, The Sixth Affiliated Hospital of Nantong University, Yancheng 224000, China.; Department of Pediatrics, Yancheng Third People's Hospital, Yancheng 224000, China., Tao Y; Institute of Pediatric Research, Children's Hospital of Soochow University, Suzhou 215003, China., Zhu F; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH 43210, USA., Jiao W; Department of Pediatrics, Yancheng Third People's Hospital, Yancheng 224000, China., Zhang Z; Institute of Pediatric Research, Children's Hospital of Soochow University, Suzhou 215003, China., Ji T; Institute of Pediatric Research, Children's Hospital of Soochow University, Suzhou 215003, China., Li T; Institute of Pediatric Research, Children's Hospital of Soochow University, Suzhou 215003, China., Fang F; Institute of Pediatric Research, Children's Hospital of Soochow University, Suzhou 215003, China., Xie Y; Institute of Pediatric Research, Children's Hospital of Soochow University, Suzhou 215003, China., Wu D; Institute of Pediatric Research, Children's Hospital of Soochow University, Suzhou 215003, China., Zhuo R; Institute of Pediatric Research, Children's Hospital of Soochow University, Suzhou 215003, China., Li X; Institute of Pediatric Research, Children's Hospital of Soochow University, Suzhou 215003, China., Chen Y; Institute of Pediatric Research, Children's Hospital of Soochow University, Suzhou 215003, China., Yin H; Institute of Pediatric Research, Children's Hospital of Soochow University, Suzhou 215003, China., Wang J; Institute of Pediatric Research, Children's Hospital of Soochow University, Suzhou 215003, China., Pan J; Institute of Pediatric Research, Children's Hospital of Soochow University, Suzhou 215003, China.

المصدر: Carcinogenesis [Carcinogenesis] 2024 Jun 10; Vol. 45 (6), pp. 424-435.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Irl Press At Oxford University Press Country of Publication: England NLM ID: 8008055 Publication Model: Print Cited Medium: Internet ISSN: 1460-2180 (Electronic) Linking ISSN: 01433334 NLM ISO Abbreviation: Carcinogenesis Subsets: MEDLINE

مواضيع طبية MeSH: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/genetics , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/pathology , Cell Proliferation*/drug effects , Xenograft Model Antitumor Assays* , Apoptosis*/drug effects , Transcription Factors*/genetics , Transcription Factors*/metabolism, Humans ; Animals ; Mice ; Cell Cycle Proteins/genetics ; Cell Cycle Proteins/antagonists & inhibitors ; Cell Cycle Proteins/metabolism ; Cell Line, Tumor ; Antineoplastic Agents/pharmacology ; Enhancer Elements, Genetic ; Bromodomain Containing Proteins

المؤلفون: Ishida H; Department of Pediatrics, Okayama University Hospital, Okayama, Japan., Imamura T; Department of Pediatrics, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan., Kobayashi R; Department of Hematology/Oncology for Children and Adolescents, Sapporo Hokuyu Hospital, Sapporo, Japan., Hashii Y; Department of Pediatrics, Osaka International Cancer Institute, Osaka, Japan., Deguchi T; Division of Cancer Immunodiagnostics, Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan., Miyamura T; Department of Pediatrics, Osaka University Graduate School of Medicine, Suita, Japan., Oda M; Department of Pediatrics, Okayama University Hospital, Okayama, Japan., Yamamoto M; Department of Pediatrics, Sapporo Medical University School of Medicine, Sapporo, Japan., Okada K; Department of Pediatric Hematology/Oncology, Osaka City General Hospital, Osaka, Japan., Sano H; Department of Pediatric Oncology, Fukushima Medical University Hospital, Fukushima, Japan., Koh K; Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan., Yuza Y; Department of Hematology and Oncology, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan., Watanabe K; Department of Hematology and Oncology, Shizuoka Children's Hospital, Shizuoka, Japan., Nishimura N; Department of Public Health, Kobe University Graduate School of Health Science, Kobe, Japan., Takimoto T; Department of Childhood Cancer Data Management, National Center for Child Health and Development, Tokyo, Japan., Moriya-Saito A; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan., Sekimizu M; Department of Pediatrics, National Hospital Organization Nagoya Medical Center, Nagoya, Japan., Suenobu S; Department of Pediatrics, Oita University, Oita, Japan., Sunami S; Department of Pediatrics, Japanese Red Cross Narita Hospital, Narita, Japan., Horibe K; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.

المصدر: Cancer medicine [Cancer Med] 2024 Jun; Vol. 13 (12), pp. e7246.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE

مواضيع طبية MeSH: Asparaginase*/therapeutic use , Asparaginase*/administration & dosage , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/mortality, Humans ; Child ; Male ; Female ; Child, Preschool ; Retrospective Studies ; Adolescent ; Infant ; Treatment Outcome ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Japan ; Antineoplastic Agents/therapeutic use

المؤلفون: Oh BLZ; Viva-University Children's Cancer Center, Khoo Teck Puat-National University Children's Medical Institute, National University Hospital, National University Health System; Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore., Vinanica N; Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore., Wong DMH; Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore., Campana D; Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore; Cancer Science Institute, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

المصدر: Haematologica [Haematologica] 2024 Jun 01; Vol. 109 (6), pp. 1677-1688. Date of Electronic Publication: 2024 Jun 01.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

مواضيع طبية MeSH: Receptors, Chimeric Antigen*/immunology , Immunotherapy, Adoptive*/methods , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/therapy , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/immunology, Humans ; T-Lymphocytes/immunology ; T-Lymphocytes/metabolism ; T-Lymphocytes/transplantation ; Animals ; Treatment Outcome ; Receptors, Antigen, T-Cell/genetics ; Receptors, Antigen, T-Cell/immunology

المؤلفون: Beyar-Katz O; Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa; The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa. o_katz@rmc.gov.il., Rowe JM; Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa; The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa; Shaare Zedek Medical Center, Jerusalem.

المصدر: Haematologica [Haematologica] 2024 Jun 01; Vol. 109 (6), pp. 1631-1633. Date of Electronic Publication: 2024 Jun 01.

نوع المنشور: Editorial; Journal Article

بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

مواضيع طبية MeSH: Receptors, Chimeric Antigen*/immunology , Immunotherapy, Adoptive*/methods , Immunotherapy, Adoptive*/adverse effects , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/therapy , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy, Humans ; Leukemia, B-Cell/therapy

المؤلفون: Neumann M; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany. m.neumann@uksh.de.; Clinical Research Unit 'CATCH ALL' (KFO 5010/1), Kiel, Germany. m.neumann@uksh.de.; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany. m.neumann@uksh.de., Beder T; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany., Bastian L; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010/1), Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany., Hänzelmann S; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany., Bultmann M; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany., Wolgast N; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010/1), Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany., Hartmann A; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010/1), Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany., Trautmann H; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany., Ortiz-Tanchez J; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany., Schlee C; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany., Schroeder M; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany., Fransecky L; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany., Vosberg S; Department of Internal Medicine III, University Hospital LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), partner site Munich, Munich, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Fiedler W; Medical Department II, Hematology and Oncology, University Hospital Hamburg Eppendorf, Hamburg, Germany., Alakel N; Medical Department I, Carl Gustav Carus University Hospital Dresden, Dresden, Germany., Heberling L; Medical Department I, Carl Gustav Carus University Hospital Dresden, Dresden, Germany., Kondakci M; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany., Starck M; Medical Department I, Hospital München-Schwabing, Schwabing, Germany., Schwartz S; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany., Raffel S; Medical Department V, University Hospital Heidelberg, Heidelberg, Germany., Müller-Tidow C; Medical Department V, University Hospital Heidelberg, Heidelberg, Germany., Schneller F; Medical Department III, Klinikum rechts der Isar, Technical University Munich, Munich, Germany., Reichle A; Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany., Burmeister T; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany., Greif PA; Department of Internal Medicine III, University Hospital LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), partner site Munich, Munich, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Brüggemann M; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010/1), Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany., Gökbuget N; Department of Medicine II, Hematology/Oncology, University Hospital, Goethe University, Frankfurt/M, Germany., Baldus CD; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010/1), Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany.

المصدر: Leukemia [Leukemia] 2024 Jun; Vol. 38 (6), pp. 1213-1222. Date of Electronic Publication: 2024 May 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

مواضيع طبية MeSH: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/genetics , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/mortality , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/pathology , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/therapy , DNA Methylation*, Humans ; Adult ; Male ; Female ; Prognosis ; Middle Aged ; Young Adult ; Adolescent ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Aged ; Biomarkers, Tumor/genetics ; Mutation ; Follow-Up Studies ; Survival Rate ; Transcriptome ; Homeodomain Proteins/genetics